ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
MPS RECEIVES CRITICAL APPROVALS AND FEEDBACK FROM AGENCIES
Published: 11/08/20, 08:47am (AEST)•5 pages